Swedish Orphan Biovitrum AB (LSIN) · Health Technology. hisse senedi canlı fiyat verisi ve teknik analiz görünümü. LSE (Londra Borsası) verilerini Alerta Chart üzerinden takip edin.
Veri erişimi kontrol ediliyor...
Swedish Orphan Biovitrum AB engages in the research, development, manufacture, and sale of pharmaceuticals. It operates through the Haematology, Immunology, and Specialty Care segments. The Haemotology segment focuses on haemophilia medicines Elocta and Alprolix. The immunology segment offers treatment for serious, disabling, and life-threatening diseases. The Specialty Care segment specializes in the treatment of genetic and metabolic diseases. The company was founded in 2001 and is headquartered in Solna, Sweden.
Alerta Chart Pro Terminal ile aynı anda 4 grafiği takip edebilir, derinlik (order book) verilerini görebilir ve 25 aktif alarm kurabilirsiniz.
Ücretsiz Başla